Andera Partners said today that it led a $20 million Series D financing round for urology-focused medical device maker ...

The FloStent™ System Promises to Redefine the BPH Care PathwayParis, France, and Milwaukee, WI, US, May 13, 2026 (GLOBE ...

The raise will support Rivermark’s pivotal trial, while allowing the medtech company to ready its FloStent system for ...

Benign Prostatic Hyperplasia Surgical Treatment Market OverviewThe global benign prostatic hyperplasia surgical treatment ...

Today, the American Urological Association (AUA) released the 2026 Management of Lower Urinary Tract Symptoms (LUTS) Attributed to Benign Prostatic Hyperplasia (BPH) Guideline, providing updated, ...

Bolding Family Dentistry is proud to announce the launch of its new website, designed to provide patients with an improved online experience and easier access to information about dental services and ...

If you’re a man over 50 reading this with a cup of coffee in one hand, there’s a fair chance you’ve already been up to the ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the relaunch of Tadalafil Tablets, an FDA-approved ...

Ashwagandha is an adaptogenic botanical traditionally used in men's wellness formulations for stress reduction and hormonal ...

When news first broke that Israeli Prime Minister Benjamin Netanyahu had been treated for prostate cancer without public disclosure, the reaction was immediate. Here was one of the most recognizable ...

Separate prescriptions to treat male pattern baldness and erectile dysfunction are available in one pill. Learn more about ...